Insulin resistance in early life predicts the future onset of psychiatric disorders and is associated with more severe disease progression in large cohort datasets.
"In large uh like big data studies, we can see that insulin resistance in early life is a marker that predicts future onset of psychiatric conditions. And it also means that people have more severe progression of psychiatric conditions." (said at 0:56:35)
Large prospective birth cohort studies (such as the Avon Longitudinal Study of Parents and Children, ALSPAC) demonstrate that broad immuno-metabolic dysfunction in childhood and genetic liability for type 2 diabetes correlate with later psychotic experiences and atypical depressive symptoms. Furthermore, cross-sectional associations between insulin resistance and depression are observed in early adulthood. However, the claim that insulin resistance in early life independently predicts the future onset and more severe progression of psychiatric disorders overstates the longitudinal evidence: specific analyses isolating childhood insulin resistance from overall adiposity and inflammation often find modest or non-significant independent longitudinal associations with subsequent depression and psychotic symptoms.
- partial: Insulin resistance and obesity, and their association with depression in relatively young … (Psychological medicine 2020)
"At age 18 years, IR and BMI were positively associated with depression. These associations may be explained by sociodemographic and lifestyle factors. There were no longitudinal associations between DGIH/BMI and depression" (abstract, results, passage verified)
pubmedfull study (doi) - partial: Childhood immuno-metabolic markers and risk of depression and psychosis in adulthood: A pr… (Psychoneuroendocrinology 2022)
"The general immuno-metabolic factor was associated with atypical depressive symptoms (aOR= 1.07; 95% CI, 1.01-1.14) and psychotic experiences (aOR=1.21; 95% CI, 1.02-1.44). The adiposity factor was associated with negative symptoms (aOR=1.07; 95% CI 1.02-1.12)." (abstract, results)
pubmedfull study (doi)